Please login to the form below

Tcelna

This page shows the latest Tcelna news and features for those working in and with pharma, biotech and healthcare.

Merck KGaA drops Ono-partnered multiple sclerosis drug

It also has a licensing deal in place for Tcelna (imilecleucel-T), a personalised treatment for secondary-progressive MS developed by Opexa Therapeutics that is in phase IIb testing with

Latest news

Currencies hit Merck Serono sales but firm says it is 'on course'

Overall groups sales down to €2.84bn for second quarter of 2013
Merck KGaA to meet 2014 financial targets one year early

and recently-licensed MS drug Tcelna (imilecleucel-T) following the decision to drop brain and lung cancer prospect cilengitide from development in the first quarter.
Merck KGaA and Opexa enter MS deal

Merck KGaA and Opexa enter MS deal. Will develop personalised T-cell based medicine Tcelna. ... During the SPMS trial, patients undergo two annual courses of Tcelna treatment, consisting of five injections per year. “

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

Pharma deals during February 2013

sales. In the other option deal, Merck Serono has acquired an option over Opexa Therapeutics' phase IIb Tcelna (imilecleucel-T) vaccine for MS (for all territories except Japan). ... Tcelna is being developed as a personalised therapy specifically

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Senior Account Manager – Healthcare Advertising: Salary TBC

Account Director, Healthcare Advertising Agency: Salary TBC

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Medical Writer - Creative and Scientific Projects: DOE

Systematic Review Lead- London: Negotiable

Account Manager- 4 days per week or full-time: Salary TBC

Healthcare PR Director: £100, 000 – £120, 000 benefits

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Graduate Scientific Editor: DOE

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Senior Medical Writer: Salary is DOE

Senior Training Manager - Surrey: Competitive Salary &Bonus

Senior Writer, Healthcare Advertising, London: Excellent package

Account Director or Senior Account Director: Salary TBC

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Market Access Consultant - Greater Manchester: Negotiable

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Subscribe to our email news alerts

PMHub

Add my company

emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....